SEC Insider Transactions from OConnell Daniel Joseph.

Last updated: 2026-03-14 11:45 UTC | Total transactions: 19

Daniel Joseph O'Connell, CEO of Acumen Pharmaceuticals ($ABOS), sold shares on the open market eight times over the past year, totaling about $163 thousand. His most recent sale occurred on January 22, 2026. These sales rank 8,833rd among 11,678 individual insiders in our database, where the average is $8.6 million across about 6.4 transactions. He made no open market purchases in this period.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Jan. 21, 2026 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer S Common Stock 9346 $1.81 883,964.0000 60,573,425 1.05% 0.02%
Jan. 22, 2026 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer S Common Stock 2689 $1.88 881,275.0000 60,573,425 0.30% 0.00%
Jan. 20, 2026 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer A Employee Stock Option (right to buy) 450000 $0.00 450,000.0000 60,573,425 9999.99% 0.74%
Jan. 20, 2026 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer A Common Stock 299800 $0.00 893,310.0000 60,573,425 50.51% 0.49%
Jan. 9, 2026 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer S Common Stock 12941 $1.76 598,898.0000 60,573,425 2.12% 0.02%
Jan. 12, 2026 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer S Common Stock 5388 $1.73 593,510.0000 60,573,425 0.90% 0.01%
Jan. 8, 2026 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer S Common Stock 8143 $1.82 611,839.0000 60,573,425 1.31% 0.01%
Jan. 5, 2026 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer S Common Stock 4649 $1.97 662,839.0000 60,573,425 0.70% 0.01%
Jan. 6, 2026 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer S Common Stock 5102 $1.97 657,737.0000 60,573,425 0.77% 0.01%
Jan. 7, 2026 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer S Common Stock 37755 $1.99 619,982.0000 60,573,425 5.74% 0.06%
Jan. 21, 2025 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer S Common Stock 12619 $1.59 667,488.0000 0 1.86% 0.00%
Jan. 3, 2025 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer S Common Stock 47778 $1.84 454,707.0000 0 9.51% 0.00%
Jan. 7, 2025 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer A Common Stock 225400 $0.00 680,107.0000 0 49.57% 0.00%
Jan. 7, 2025 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph Chief Executive Officer A Employee Stock Option (right to buy) 338000 $0.00 338,000.0000 0 9999.99% 0.00%
Jan. 19, 2024 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph President and CEO S Common Stock 15200 $3.47 502,485.0000 0 2.94% 0.00%
Jan. 2, 2024 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph President and CEO A Common Stock 401000 $0.00 517,685.0000 0 343.66% 0.00%
Jan. 2, 2024 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph President and CEO A Employee Stock Option (right to buy) 602000 $0.00 602,000.0000 0 9999.99% 0.00%
Jan. 17, 2023 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph President and CEO A Common Stock 114000 $0.00 116,685.0000 0 4245.81% 0.00%
Jan. 17, 2023 Acumen Pharmaceuticals, Inc. $ABOS OConnell Daniel Joseph President and CEO A Employee Stock Option (right to buy) 472500 $0.00 472,500.0000 0 9999.99% 0.00%